Company profile JAGX
There is not enough data for chronic and debilitating diarrhea to provide analysis
There is not enough data for chronic and debilitating diarrhea to provide correlation calculation
There is not enough data for chronic and debilitating diarrhea to provide analysis
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Mytesi expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 119 | 262 120.2% QoQ | 124 -52.7% QoQ | 227 83.1% QoQ |
| 2020 | 106 -10.9% YoY -53.3% QoQ | 158 -39.7% YoY 49.1% QoQ | 211 70.2% YoY 33.5% QoQ | 266 17.2% YoY 26.1% QoQ |
| 2021 | 166 56.6% YoY -37.6% QoQ | 171 8.2% YoY 3.0% QoQ | 75 -64.5% YoY -56.1% QoQ | 82 -69.2% YoY 9.3% QoQ |
| 2022 | 63 -62.0% YoY -23.2% QoQ | 82 -52.0% YoY 30.2% QoQ | 236 214.7% YoY 187.8% QoQ | 149 81.7% YoY -36.9% QoQ |
| 2023 | 118 87.3% YoY -20.8% QoQ | 166 102.4% YoY 40.7% QoQ | 59 -75.0% YoY -64.5% QoQ | 186 24.8% YoY 215.3% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Mytesi was 11.59 per week. The last year interest of Mytesi compared to the last 5 years has changed by -17.52%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -35.84%.
After 39 days of this quarter the interest is at 27.0. Based on that we can calculate that during remaining 52 days it will total up to 63.0. Crofelemer expected interest is significantly lower compared to previous quarter (-62.5%) and same quarter last year (-42.2%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 55 | 66 20.0% QoQ | 127 92.4% QoQ | 41 -67.7% QoQ |
| 2020 | 68 23.6% YoY 65.9% QoQ | 96 45.5% YoY 41.2% QoQ | 86 -32.3% YoY -10.4% QoQ | 122 197.6% YoY 41.9% QoQ |
| 2021 | 137 101.5% YoY 12.3% QoQ | 84 -12.5% YoY -38.7% QoQ | 216 151.2% YoY 157.1% QoQ | 24 -80.3% YoY -88.9% QoQ |
| 2022 | 110 -19.7% YoY 358.3% QoQ | 79 -6.0% YoY -28.2% QoQ | 44 -79.6% YoY -44.3% QoQ | 63 162.5% YoY 43.2% QoQ |
| 2023 | 109 -0.9% YoY 73.0% QoQ | 124 57.0% YoY 13.8% QoQ | 105 138.6% YoY -15.3% QoQ | 168 166.7% YoY 60.0% QoQ |
| 2024 | 27 -75.2% YoY -83.9% QoQ | - | - | - |
The average 5 years interest of Crofelemer was 7.48 per week. The last year interest of Crofelemer compared to the last 5 years has changed by 25.94%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 59.66%.
There is not enough data for Short bowel syndrome with intestinal failure to provide analysis
There is not enough data for Short bowel syndrome with intestinal failure to provide correlation calculation
There is not enough data for Short bowel syndrome with intestinal failure to provide analysis
There is not enough data for supportive care for diarrhea relief in inflammatory bowel diseases to provide analysis
There is not enough data for supportive care for diarrhea relief in inflammatory bowel diseases to provide correlation calculation
There is not enough data for supportive care for diarrhea relief in inflammatory bowel diseases to provide analysis
There is not enough data for diarrhea-predominant irritable bowel syndrome to provide analysis
There is not enough data for diarrhea-predominant irritable bowel syndrome to provide correlation calculation
There is not enough data for diarrhea-predominant irritable bowel syndrome to provide analysis
There is not enough data for idiopathic/functional diarrhea to provide analysis
There is not enough data for idiopathic/functional diarrhea to provide correlation calculation
There is not enough data for idiopathic/functional diarrhea to provide analysis
There is not enough data for NP-300 to provide analysis
There is not enough data for NP-300 to provide correlation calculation
There is not enough data for NP-300 to provide analysis
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Canalevia expected interest is significantly lower compared to same quarter last year (-100.0%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 80 | 156 95.0% QoQ | 24 -84.6% QoQ | 144 500.0% QoQ |
| 2020 | 79 -1.2% YoY -45.1% QoQ | 39 -75.0% YoY -50.6% QoQ | 23 -4.2% YoY -41.0% QoQ | 140 -2.8% YoY 508.7% QoQ |
| 2021 | 183 131.6% YoY 30.7% QoQ | 202 417.9% YoY 10.4% QoQ | 67 191.3% YoY -66.8% QoQ | 114 -18.6% YoY 70.1% QoQ |
| 2022 | 74 -59.6% YoY -35.1% QoQ | 0 -100.0% YoY -100.0% QoQ | 89 32.8% YoY inf% QoQ | 20 -82.5% YoY -77.5% QoQ |
| 2023 | 201 171.6% YoY 905.0% QoQ | 142 inf% YoY -29.4% QoQ | 82 -7.9% YoY -42.3% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Canalevia was 7.12 per week. The last year interest of Canalevia compared to the last 5 years has changed by 5.06%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -8.67%.
There is not enough data for chemotherapy-induced diarrhea in dogs to provide analysis
There is not enough data for chemotherapy-induced diarrhea in dogs to provide correlation calculation
There is not enough data for chemotherapy-induced diarrhea in dogs to provide analysis
There is not enough data for exercise-induced diarrhea in dogs. to provide analysis
There is not enough data for exercise-induced diarrhea in dogs. to provide correlation calculation
There is not enough data for exercise-induced diarrhea in dogs. to provide analysis